First Trust Advisors LP Biocryst Pharmaceuticals Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Advisors LP holds 593,466 shares of BCRX stock, worth $4.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

593,466

Holding current value

$4.49 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $3.8 Million - $5.16 Million	593,466 New	593,466 $4.51 Million
Q1 2024 May 13, 2024	SELL	$4.89 - $7.65 $94,557 - $147,928	-19,337 Reduced 12.03%	141,387 $718,000
Q4 2023 Feb 13, 2024	BUY	$4.98 - $6.77 $800,405 - $1.09 Million	160,724 New	160,724 $962,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $94,656 - $119,816	13,600 Added 8.34%	176,763 $1.24 Million
Q1 2023 May 15, 2023	SELL	$7.94 - $11.84 $321,339 - $479,176	-40,471 Reduced 19.87%	163,163 $1.36 Million
Q4 2022 Feb 09, 2023	BUY	$10.5 - $14.2 $824,943 - $1.12 Million	78,566 Added 62.82%	203,634 $2.34 Million
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $1.72 Million - $2.37 Million	-159,783 Reduced 56.09%	125,068 $1.58 Million
Q2 2022 Aug 12, 2022	BUY	$7.89 - $17.88 $866,590 - $1.96 Million	109,834 Added 62.76%	284,851 $3.01 Million
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $1.51 Million - $2.58 Million	-130,734 Reduced 42.76%	175,017 $2.85 Million
Q4 2021 Feb 08, 2022	BUY	$11.18 - $15.46 $663,029 - $916,855	59,305 Added 24.06%	305,751 $4.24 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $1.43 Million - $1.77 Million	-100,387 Reduced 28.94%	246,446 $3.54 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $3.29 Million - $5.98 Million	346,833 New	346,833 $5.48 Million
Q3 2019 Nov 04, 2019	SELL	$2.5 - $3.73 $124,167 - $185,257	-49,667 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$2.91 - $9.15 $144,530 - $454,453	49,667 New	49,667 $188,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Biocryst Pharmaceuticals Inc Transaction History